Edition:
United States

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

43.16USD
21 Sep 2018
Change (% chg)

$-2.59 (-5.66%)
Prev Close
$45.75
Open
$45.28
Day's High
$45.70
Day's Low
$43.00
Volume
688,281
Avg. Vol
254,874
52-wk High
$82.68
52-wk Low
$33.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -1.707
Mar '18 0.00 -1.734
FY 2017 Dec '17 0.00 -1.444
Sep '17 0.00 -1.860
Jun '17 0.00 -1.918
Mar '17 0.00 -1.797
FY 2016 Dec '16 0.00 -1.284
Sep '16 0.00 -0.772
Jun '16 0.00 -0.623
Mar '16 0.00 -0.647
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 9 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 9 0.00 0.00 0.00 0.00
Year Ending Dec-18 10 10.00 100.00 0.00 10.00
Year Ending Dec-19 11 22.73 150.00 0.00 28.34
Earnings (per share)
Quarter Ending Sep-18 12 -1.64 -1.43 -1.75 -1.21
Quarter Ending Dec-18 12 -1.32 -1.05 -1.63 -1.05
Year Ending Dec-18 12 -6.41 -6.17 -6.69 -5.58
Year Ending Dec-19 12 -5.33 -1.30 -7.75 -5.08
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.33 32.69
P/E High - Last 5 Yrs. -- 278.75 47.23
P/E Low - Last 5 Yrs. -- 97.93 24.79
Beta 2.20 0.61 0.87
Price to Sales (TTM) -- 110.30 6.46
Price to Book (MRQ) 6.58 12.48 3.90
Price to Tangible Book (MRQ) 6.58 18.90 5.96
Price to Cash Flow (TTM) -- 62.41 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 175.09 8.38
Sales (TTM) vs TTM 1 Yr. Ago -- 92.96 6.69
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago 11.01 283.36 25.56
EPS (TTM) vs TTM 1 Yr. Ago -16.88 -- --
EPS - 5 Yr. Growth Rate -- 23.65 7.60
Capital Spending - 5 Yr. Growth Rate 22.89 38.57 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.19
Current Ratio (MRQ) 5.40 5.49 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.24
Total Debt to Equity (MRQ) 0.09 18.62 14.06
Interest Coverage (TTM) -455.18 -215.83 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.67
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -177.00 15.88
Operating Margin (TTM) -- -607.80 3.65
Operating Margin - 5 Yr. Avg. -- -190.63 11.00
Pre-Tax Margin (TTM) -- -604.88 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -193.42 11.19
Net Profit Margin (TTM) -- -599.69 0.70
Net Profit Margin - 5 Yr. Avg. -- -191.17 7.52
Effective Tax Rate (TTM) -- 11.60 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.16 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,335,375 714,979,821
Net Income/Employee (TTM) -3,069,649 -5,831,664 82,568,832
Receivable Turnover (TTM) -- 4.20 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.00 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -88.34 0.80 9.75
Return on Assets - 5 Yr. Avg. -39.14 2.53 10.91
Return on Investment (TTM) -105.99 1.50 12.72
Return on Investment - 5 Yr. Avg. -41.73 2.04 14.03
Return on Equity (TTM) -106.03 0.19 14.85
Return on Equity - 5 Yr. Avg. -42.93 -2.23 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -109.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Esperion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.06 -13.71 41 74
13 Week 10.98 4.36 99 56
26 Week -38.49 -45.66 36 45
52 Week -12.58 -25.38 89 88
YTD -34.45 -40.18 49 80
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 203
Total Shares Held: 32,760,335
3 Mo. Net Change: 4,384,219
# New Positions: 26
# Closed Positions: 66
# Increased Positions: 110
# Reduced Positions: 116
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.